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formation in vivo
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Abstract
Background: The mammary glands of pigs share many functional and morphological similarities with the breasts
of humans, raising the potential of their utility for research into the mechanisms underlying normal mammary
function and breast carcinogenesis. Here we sought to establish a model for the efficient manipulation and
transformation of porcine mammary epithelial cells (pMEC) in vitro and tumor growth in vivo.
Methods: We utilized a vector encoding the red florescent protein tdTomato to transduce populations of pMEC
from Yorkshire –Hampshire crossbred female pigs in vitro and in vivo. Populations of primary pMEC were then
separated by FACS using markers to distinguish epithelial cells (CD140a-) from stromal cells (CD140a+), with or
without further enrichment for basal and luminal progenitor cells (CD49f+). These separated pMEC populations
were transduced by lentivirus encoding murine polyomavirus T antigens (Tag) and tdTomato and engrafted to
orthotopic or ectopic sites in immunodeficient NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ (NSG) mice.
Results: We demonstrated that lentivirus effectively transduces pMEC in vitro and in vivo. We further established
that lentivirus can be used for oncogenic-transformation of pMEC ex vivo for generating mammary tumors in vivo.
Oncogenic transformation was confirmed in vitro by anchorage-independent growth, increased cell proliferation, and
expression of CDKN2A, cyclin A2 and p53 alongside decreased phosphorylation of Rb. Moreover, Tag-transformed
CD140a- and CD140a-CD49f + pMECs developed site-specific tumors of differing histopathologies in vivo.
Conclusions: Herein we establish a model for the transduction and oncogenic transformation of pMEC. This is the first
report describing a porcine model of mammary epithelial cell tumorigenesis that can be applied to the study of
human breast cancers.
Keywords: Breast cancer model, Microenvironment, Lentivirus transformation, Xenograft, Pig
Background
Preclinical studies of breast cancer are limited by a lack
of suitable models recapitulating aspects of human
physiology and the biology of the human breast. Ap-
proximately 90 % of cancer treatments stemming from
preclinical screens performed using xenografts in ro-
dents fail during clinical trials [1], highlighting intrinsic
genetic, physiological [2, 3] and morphological [4] differ-
ences between humans and mice. The pig offers a prom-
ising alternative to traditional rodent models given they
share pronounced genomic [5] and biological [6] similar-
ities to humans. As such, pigs have increasingly become
an integral species for translational research, particularly
for preclinical toxicology studies and as a biomedical
model for human cardiovascular, integumentary and
gastrointestinal systems [7].
While the mammary glands of female pigs have only
been infrequently cited as a model for the human breast,
they closely recapitulate several important aspects of hu-
man breast biology. Development of the mammary tis-
sue in pigs from embryogenesis [8] through puberty [9]
and gestation [10] parallels that of the human breast
[11]. While pigs have an average of 10–14 mammary
glands, each has multiple (2–4) galactophores that drain
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to the nipple and form the primary duct from which the
parenchymal tissue develops [12]. Humans also have
multiple galactophores per nipple, while the mouse has
only one [13]. The histomorphology of the porcine
mammary gland and human breast has been similarly
described as having terminal ductal lobular units
(TDLU) embedded within fibrous inter-and intralobular
connective tissues [9, 11], which contrasts to the simple
ductal network and adipose-rich stroma of the mouse
mammary gland [4]. Importantly, intrinsic structural dif-
ferences between the mammary glands of rodents and
humans likely influence tumorigenic risk given that the
stroma directs proliferative, morphogenic and hormonal
responses by the epithelium [14–16]. Furthermore, the
relative abundance of different TDLU morphotypes in
the human breast can influence breast cancer risk, where
the least-differentiated TDLU type 1 (TDLU-1) is most
prone to transformation [17]. A porcine model of hu-
man breast cancer would stand to address many of these
interactions that underlie breast development and
tumorigenesis [18]. Moreover, the size and positioning
of the voluminous mammary glands will allow for the
assessment of multiple treatments or endpoints within
an animal and over time using serial biopsies [19].
Further to the above, few reports detail methods to
isolate and genetically manipulate the mammary epithe-
lial cells (pMEC) in pigs. The objective of this study was
to establish methods of lentivirus-mediated transform-
ation of pMEC as a first step toward developing a novel
model for human breast cancer. We hypothesized pMEC
would undergo oncogene-induced transformation to
yield tumors with a histopathology resembling human
breast cancers. Herein, we report the successful lentiviral
transduction of porcine mammary cells in vitro and tis-
sue in vivo, formation of tumors by transformed pMEC
in immunocompromised mice, and the precocious ex-
pansion of TDLU when transformed pMEC were iso-
grafted into the pig mammary gland.
Methods
Experimental design
We initially conducted experiments to determine the ef-
ficiency of using lentivirus for the transduction of pMEC
in vitro and in vivo. In study one we sought to develop
and optimize methods for the collection and dissociation
of mammary tissue from nulliparous pigs for transduc-
tion in vitro. In study two we transduced pig mammary
tissue in vivo by direct instillation of non-oncogenic
lentivirus into the mammary gland duct or parenchyma.
For study three, we sought to determine whether pMEC
transduced with non-oncogenic lentivirus in vitro could
develop typical mammary structures when transplanted
back to the mammary fat pads of respective donor pigs.
Finally, in studies four and five, pMEC were transformed
in vitro by oncogenic lentivirus and either isografted to
the mammary gland of donor pigs (study four) or xeno-
grafted to the mammary fat pad of immunocomprom-
ised mice (study five).
Animals
All experimental protocols for animal experimentation
underwent prior ethical review and were approved by
the UC Davis Animal Care and Use Committee follow-
ing guidelines set forth by the Association for Assess-
ment and Accreditation of Laboratory Animal Care and
the Guide for the Care and Use of Agricultural Animals
in Research and Teaching (protocol #17675). For study
one and study five, mammary tissue was obtained at
necropsy from healthy nulliparous Yorkshire × Hamp-
shire pigs obtained from the specific pathogen-free
swine facility at UC Davis when they were 3–5 months
of age (n = 8 and n = 4, respectively). For study two (n = 9
pigs from two litters), study three (n = 8 pigs from two
litters), and study four (n = 4 pigs from two litters) pigs
were healthy, experimentally naïve 4 week-old Yorkshire ×
Hampshire females. For studies two, three and four, piglets
were selected that possessed at least twelve mammary
glands, which permitted an individual pig to carry experi-
mental treatments and controls within separate mammary
glands. Piglets were housed indoors in a temperature-
controlled facility (25–27 °C), as littermate pairs, were fed
twice daily and had ad libitum access to water. Pigs were
monitored daily for any changes in behavior or health
status. During surgical procedures, pigs were assessed for
changes in body temperature, heart rate and respiration.
All surgical procedures involving pigs were carried out in
a disinfected surgical suite designed for accommodating
large animals.
In study five, 20 experimentally naïve female NOD scid
gamma (NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ (NSG)) mice
(The Jackson Laboratory, Sacramento, CA; n = 4 per
pMEC line) between 4 and 35 weeks of age (Table 1)
were maintained in littermate groups with ad libitum
access to food and water. Mice were housed in a
pathogen-free barrier facility under conditions of con-
stant temperature (20–23 °C), humidity (45–65 %), and
a 14 h light/10 h dark cycle. Tumor formation was
assessed weekly by palpation, and tumor diameter
recorded every 2d once they reached 1 mm diameter.
During surgical procedures, mice were monitored for
toe-pinch reflex and respiration rate. Surgical procedures
were carried out within a disinfected biosafety cabinet to
minimize pathogen exposure.
Pigs in study two received daily 17β-estradiol injections
(IM, 0.1 mg/kg; Sigma Aldrich, St. Louis, MO) for 7d after
lentivirus instillation to stimulate MEC proliferation [9].
Similarly, pigs in studies three and four received daily 17β-
estradiol for 7d prior to excision of mammary tissue. Upon
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Table 1 pMEC were sorted to remove fibroblasts (CD140-), and some selected for expression of CD49f or tdTomato, and then transduced at various passages (PT) with one of
the lentiviral constructs PGK-Tantigen (PGKT), CMV-tdTomato (CMVT) or PGKT-CMVT (PTCT)
Cell line FACS PT In vitro morphology Number Age PI Cells (#) Matrix Site E + P Tumor diameter
(mm)
Weeks
carried
in vivo characteristics
ss071712 PGKT CD140- 1 Cobblestone, no foci 3 67d 6 1×105 Hydrogel MG No N/a 16.7 N/a
ss071712 CMVT CD140- 6 1×105 Hydrogel MG No N/a 16.7
ss071712 PGKT CD140- 1 7 74d 6 1×105 Hydrogel MG No N/a 15.7 N/a
ss071712 CMVT CD140- 6 1×105 Hydrogel MG No N/a 15.7
27-3 PTCT CD140-tdTomato+ 1 Foci, radial outgrowth 4 30d 7 5×105 Hydrogel MG No <1 mm 19.5 Normal ductal epithelium
27-3 PTCT CD140-tdTomato+ 7 5×105 Hydrogel SC (Rear) No N/a 19.5 N/a
28-3 PTCT CD140- 1 Elongated, some foci 4 30d 10 5×105 Hydrogel MG No 15.3 ± 1.5 18.5 Fibrosis, vimentin positive
28-3 PTCT CD140- 10 5×105 Hydrogel SC (Rear) No 12.3 ± 1.1 18.5
27-1 PTCT CD140-tdTomato+ 1 Cobblestone, no foci 4 30d 11 5×105 Hydrogel MG No N/a 36.4 N/a
27-1 PTCT CD140-tdTomato+ 11 5×105 Hydrogel SC (Rear) No N/a 36.4
28-6 PTCT CD140-tdTomato+ 1 Foci, rapid proliferation 4 30d 11 5×105 Hydrogel MG No <1 mm 42 Fibrosis, squamous epithelium
28-6 PTCT CD140-tdTomato+ 11 5×105 Hydrogel SC (Rear) No N/a 42 N/a
ss020513_1 PTCT CD140- CD49f+ 1 Cobblestone, no foci 4 102d 3 4×105 Hydrogel SC (Shoulder) No 5.3 ± 0.6 32 Glandular, squamous epithelium,
CK8/18 positive
ss020513_1 PTCT CD140- CD49f+ 242d 3 1×106 Matrigel SC (Flank) Yes 6.0 ± 0.4 10
ss020513_2 PTCT CD140- CD49f+ 1 Cobblestone, no foci 4 3 8×105 Matrigel SC (Flank) Yes 6.2 ± 1.2 10
ss082112_PTCT CD140- 6 Cobblestone, no foci 4 59d 10 1×106 Matrigel MG Yes <1 mm 10.6 Normal ductal epithelium
ss082112_PTCT CD140- 6 11 1×106 Matrigel SC (Rear) Yes 7.21 ± 0.2 10.6 Glandular, squamous epithelium
NSG mice (n = 3-7), at various ages, were injected with cells at various passages post-transduction (PI) in hydrogel or Matrigel into mammary gland fat pads (MG) or subcutaneously (SC), with or without implanted estrogen
(E) and progesterone (P) pellets. Cells were grown in the mice for up to 42 weeks and the widest diameter (±SEM) and features of growths are indicated
Row
son-H
odelet
al.BM
C
Cancer
 (2015) 15:562 
Page
3
of
16
reinstillation of lentivirus-transduced cells, a 17β-estradiol/
cholesterol pellet (0.05 mg/kg) was placed subcutaneously,
reducing the need for daily hormone injections. All pigs
serving as donors for mammary tissue received penicillin
intramuscularly 24 h prior to tissue collection to reduce the
potential bacterial contamination of cultures. NSG mice
carrying pMEC lines ss020513_1 and ss020513_2 (n = 4)
and ss082112 (n = 4) received a pellet containing 2 μg 17β-
estradiol and 0.75 mg progesterone (Sigma-Aldrich) at the
time of cell injection to promote the proliferation of
engrafted cells.
Primary mammary cell isolation
In studies one and four, immediately following exsanguin-
ation of pigs, the skin was disinfected, the nipple retracted
and ~1 g of mammary tissue excised (n = 5 glands). In
study three, pMEC were obtained by removing endogen-
ous parenchyma from six mammary glands from five-
week old pigs under isoflurane anesthesia using a cleared
mammary gland procedure essentially as described [20].
Analgesic (banamine, 2–5 mg/kg) was administered
postoperatively.
Organoid preparation
Minced mammary tissue was digested (1.5 mg/ml colla-
genase A (Roche, San Francisco, CA; 75 μg/ml DNase I,
Roche; 1 mg/ml hyaluronidase, MP Biomedicals, Santa
Ana, CA) in growth media (10 % fetal bovine serum
[FBS], DMEM/F-12, penicillin G/streptomycin sulfate/
amphotericin B) at 37 °C for 3 h. Organoids (40–100 μm
diameter) were plated in primary porcine mammary epi-
thelial media (modified from MEGM [21] as a 1:1 mix of
MCDB170 (US Biological, Salem, MA) and DMEM/F-12
(CellGro, Manassas, VA) with penicillin G/streptomycin
sulfate/amphotericin B, 0.5 % FBS, bovine insulin
(7.5 μg/mL, Sigma-Aldrich), human EGF (5 ng/mL,
Millipore, Billerica, MA), hydrocortisone (0.25 μg/mL,
Sigma-Aldrich), human apo-transferrin (2.5 μg/mL,
Sigma-Aldrich), ethanolamine (0.1 mM, Sigma-Aldrich),
o-phosphoethanolamine (0.1 mM Sigma-Aldrich), bo-
vine pituitary extract (35 μg/mL, Gemini Bio-Products,
West Sacramento, CA), and lipid-rich bovine serum al-
bumin (0.1 %, Gemini Bio-Products).
Cell culture
Primary pMEC were maintained in porcine mammary
epithelial media or growth media, and were differentially
trypsinized to reduce the number of contaminating fi-
broblasts [21]. HEK293FT cells (Invitrogen, Grand
Island, NY) were maintained in HEK293FT media
(DMEM, 10 % FBS, penicillin G/streptomycin sulfate,
non-essential amino acids and 1 mM sodium pyruvate).
NIH/3 T3 cells (ATCC) were maintained in high glu-
cose DMEM (Hyclone Laboratories, GE Healthcare Life
Sciences, Logan UT) with 10 % FBS, 10 mM Hepes,
1 mM sodium pyruvate, penicillin G/streptomycin
sulfate.
Vectors and virus
The human elongation factor 1α (EF1α)-tdTomato and
phosphoglycerate kinase (PGK)-tdTomato plasmids were
generated from pLVX-IRES-tdTomato (cytomegalovirus
(CMV)-tdTomato; Clontech, Mountain View, CA) by
cloning the EF1α promoter from pEF6/myc-His C (Invi-
trogen) or the human PGK promoter (GenBank:NG_
008862.1) from the pMNDU3-PGK-Luc plasmid (UC
Davis Vector Core, Sacramento, CA) by PCR (Additional
file 1: Figure S1A). The PGK-T antigens (Tag)-CMV-tdTo-
mato construct (Additional file 1: Figure S1B) was gener-
ated by first constructing pLVX-PGK-Tag. IRES-tdTomato
was excised from pLVX-PGK-tdTomato to give pLVX-
PGK. The Tag sequences encoding mouse polyomavirus
small Tag (ST), middle Tag (MT) and large Tag (LT; Gen-
Bank:J02288) were amplified from p53.A6.6 (pPY-1;
ATCC, Manassas, VA) and ligated into pLVX-PGK to gen-
erate pLVX-PGK-Tag. The CMV promoter was excised
from pLVX-IRES-tdTomato and ligated into pLVX-PGK-
Tag to generate pLVX-PGK-Tag-CMV. The tdTomato
coding sequence was amplified from pLVX-IRES-
tdTomato and ligated into pLVX-PGK-Tag-CMV to
generate pLVX-PGK-Tag-CMV-tdTomato. All con-
structs were sequence verified.
Lentiviral supernatants for PGK-Tag-CMV-tdTomato
were prepared by the University of California San Fran-
cisco viral core and titrated by flow cytometry (9.3 × 107
transduction units [TU]/ml). CMV-tdTomato viral super-
natant was produced by triple transfection of HEK293FT
cells in Opti-MEM I (Invitrogen) with packaging vector
(16 μg/150 cm2 cells; pCMV-dR8.91, UC Davis Vector
Core), envelope vector (3.2 μg/150 cm2 cells; pMDG-
VSVG, UC Davis Vector Core) and transfer vector (16 μg/
150 cm2 cells; pLVX-IRES-tdTomato) with Lipofectamine
2000 (Invitrogen). Lentiviral particles were concentrated
by 100 kDa cut-off centrifugation (Millipore).
Viral stocks were titrated in HEK293FT cells using
qPCR [22]. The woodchuck hepatitis virus posttranscrip-
tional regulatory element (WPRE) was used to measure in-
tegration and values normalized to the number of human
albumin copies (WPRE Fwd GCGTCTGGAACAATCAAC
CT and Rev GGCATTAAAGCAGCGTATCC; hAlbumin
[GenBank:152112963] Fwd GTGCTGCCTCGTAGAGTT
TTCTG and Rev TCAATAGCCATGTGACCAGTGACT).
Fluorescence activated cell sorting
Primary pMEC cultures were expanded for 13-14d post-
isolation with two differential trypsinizations using Accu-
tase (Innovative Cell Technologies, Mira Mesa, CA) to
remove fibroblasts, followed by Accumax (Innovative Cell
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Technologies) to dislodge pMEC. Single cells were incu-
bated with phycoerythrin-conjugated anti- CD140a (BD
Biosciences, Franklin Lakes, NJ) and/or biotinylated anti-
human CD49f (AbD Serotec, Oxford, UK), followed by
streptavidin-Alexa 488 (Jackson Immunoresearch) and pro-
pidium iodide (10 μg/ml) and sorted using a MoFlo cell
sorter (Cytomation, West Lafayette, IN).
Viral transduction in vitro
Adherent pMEC were transduced overnight using a
multiplicity of infection (MOI) of 100 for PGK-
tdTomato, EF1α-tdTomato or CMV-tdTomato, or an
MOI of 20 for PGK-Tag-CMV-tdTomato, along with
polybrene (6 μg/mL; Millipore). For study four, cultures
of CD140a- pMEC were transduced with PGK-Tag
(ss071712), pLVX-PGK-Tag-CMV-tdTomato (ss082112,
27–1, 27–3, 28–3) or CMV-tdTomato (ss071712). Two
pMEC lines (ss020513_1, ss020513_2) were sorted to be
CD140a-/CD49f + then transduced with PGK-Tag-CMV-
tdTomato. A subset of CD140a- pMEC transduced with
PGK-Tag-CMV-tdTomato were sorted for tdTomato +
either 7d (27–3, 28–3) or 17d later (27–1, 28–6) de-
pending on the initial number of CD140a- pMEC.
Viral transduction in vivo
In study two, saline or lentivirus (CMV-tdTomato, 5 × 106
TU; EF1α-tdTomato, 1 × 107 TU and PGK-tdTomato, 5 ×
106 TU with or without 6 μg/ml polybrene was instilled
into the left (with polybrene; one gland/treatment) and
right (without polybrene; one gland/treatment) thoracic
and abdominal mammary glands of pigs (n = 9) via one of
the two mammary ducts (intraductal) under isoflurane
anesthesia. Additionally, saline or lentivirus suspension
with 6 μg/ml polybrene was injected directly into the
mammary parenchyma (20–25 mm subcutaneously;
intramammary) in the four remaining mammary glands
of each pig (one gland/treatment). Mammary glands
were harvested at necropsy 5, 10 or 15 d later, and
snap frozen or fixed in 4 % paraformaldehyde.
Ex vivo transduction and grafting
In study three, dissociated mammary organoids (n = 30)
were transduced overnight (MOI = 100) with PGK-
tdTomato, CMV-tdTomato, EF1α-tdTomato, CMV-Tag,
EF1α-Tag, PGK-Tag or no vector (control) with poly-
brene (6 μg/ml). After 24 h (n = 4 pigs) or 8d (n = 6 pigs)
cultures of organoids were trypsinized and resuspended
in serum-free media. Donor pigs were anesthetized with
isoflurane and cells reinstilled via two intramammary in-
jections/gland (0.9–4.5×105 cells/injection; n = 2 glands/
construct/pig) and each site closed with Vetbond (3 M, St.
Paul, MN). The isografted mammary glands were har-
vested 3–5 weeks later, minced, and randomly divided
for snap freezing in liquid N2 or fixation in 4 % paraf-
ormaldehyde.
In study four, lentivirus-transduced pMEC were
injected into NSG mice under isoflurane anesthesia. A
range of 0.4-1 × 106 pMEC resuspended in 20 μL of
HyStem-C hydrogel (n = 46 injected sites; Glycosan
Biosystems, Alameda, CA) or Matrigel HC (n = 24
injected sites; BD Biosciences) was injected either
subcutaneously or directly into the mammary gland.
For instillation of cells into the mammary gland, a
small skin incision (~5 mm) was made to visualize
accurate placement within the mammary fat pad.
Mice were treated postoperatively with a single dose
of analgesic (buprenorphine; 0.05 mg/kg) and were
monitored once daily over 7d for changes in health
and behavior. Table 1 summarizes the mice and cell
injections used.
In vitro assays
Cell number was assayed using a methylene blue
assay [23]. Cells were plated in 96 well-plates at 2000
cells/well (n = 6/cell line) on d0, and medium changed
every 2d.
Cells (20,000/well) were resuspended in 0.35 % agar
in growth medium and poured onto a base layer (0.7 %
agar in growth media), with growth medium changed
every 2d. After 21d, cells were stained (0.04 % crystal
violet, 2.1 % citric acid), imaged and colonies >50 μm
counted using ImageJ (NIH; http://rsb.info.nih.gov/ij/).
Mammary gland and tumor whole mounts
Semi-thick tissue sections were dehydrated through
graded ethanols to xylene (study three) or graded glycerol
(study four) as described [24]. Sections were imaged using
a fluorescent dissecting microscope. The percent red area
was calculated using Image J. Regions positive for red
fluorescence were dissected and processed to paraffin for
hematoxylin and eosin staining (H&E) and immunohisto-
chemistry. Regions having dense ductal structures (study
three, PGK-Tag mammary glands) were microdissected,
paraffin-embedded and sectioned for histology (H&E) and
genomic DNA extraction.
Western blotting
Cells (1–3 × 106) were lysed and sonicated in buffer with
protease and phosphatase inhibitors, and western blots
performed as described [25]. Antibodies were from
Santa Cruz Biotechnology (rat polyomavirus early,
cyclin D1, and p53), Cell Signaling Technology (Rb,
phospho Rb, MAPK1/3 and phospho MAPK1/3)) and
Jackson ImmunoResearch (HRP-conjugated secondary
antibodies).
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Genomic DNA extraction and PCR detection of
integration
Genomic DNA was extracted from paraffin-embedded
tissues as described [26] using combined heating and
non-heating protocols. DNA quality was assessed using
primers for the porcine prolactin receptor gene [27].
The incidence of lentiviral integration in studies two and
three was determined using primer sets specific to tdTo-
mato (Clontech; tdTomatoFin Fwd CTCCGAGGACAA-
CAACATGG and Rev CTTGGTCACCTTCAGCTTGG;
CMVtdTomato Fwd AACACGATGATAATATGGTGA
GCAAGGG and TdTomatointernal Rev GACAGCTT
CTTGTAATCGGGGATGTC) or amplified a product
specific for PGK-Tag (PGKTagspec5P TGAAGATGTA
AAGGGTCAAATAGC and PGKspec3P-2 AAGGCATT
AAAGCAGCGTATC).
RT-qPCR and qPCR (study two)
Total RNA was extracted and reverse transcribed as de-
scribed [28]. Primers spanned across exons of LEF1 (Fwd
GACGAGCACTTTTCTCCAGGA, Rev TAATCTGTCC
AACACCACCCG [GenBank:XM_005666939]), cyclin D1,
(Fwd CCCTCCGTGTCCTACTTCAA, Rev CAGGCGGC
TCTTTTTCAC [GenBank:AK400348)], cyclin A2, (Fwd
TTGTGGGCACTGCTGCTATG, Rev GCAAGGACTTT
CAAAACGAGGTG [GenBank:GQ265874]), MYC, (Fwd
CGCTTTTTGGACGCTGGATT, Rev TTCTCCTCCTC
GTCGCAGTA [GenBank:X97040]), RB1 (Rb), (Fwd ACG
CCAACAAAAATGACTCC, Rev GTTGCCTCCTTCAG
CACTTC [GenBank: JX099502]), TP53 (p53), (Fwd CC
ATCCTCACCATCATCACACT, Rev CTCTGTGCGGC
GGTCTCT [GenBank:NM_213824]), P21, (Fwd GCAGA
CCAGCATGACAGATT, Rev TGTTTCCAGCAGGACA
AGG [GenBank:XM_001929558]), P16, (Fwd GAGGGC
TTCCTGGACACTTTG, Rev TGCAGTATCTCTGGG
TTTCAATGA; [GenBank:AJ316067]) and 18S ribosomal
RNA, (Fwd ACGGCTACCACATCCAAGGA, Rev CCA
ATTACAGGGCCTCGAAA [GenBank: AF179868]). All
PCR products were sequenced. RT-qPCR was as described
[28], where relative transcript abundance was calculated
using a 5-point standard curve obtained by 5-fold serial
dilutions of a pMEC complementary DNA pool. The
average relative expression for each sample was normal-
ized to 18S ribosomal RNA levels [29].
DNA was purified from tissues homogenized in Tri-
Reagent (Molecular Research Center, Inc, Cincinnati,
Ohio). Genomic DNA (40 ng) was amplified with tdTo-
matoFin primers using qPCR [28]. Standard curves were
generated from genomic DNA extracted from mouse
mammary tumor cells (SSM-2) transduced with EF1α-
tdTomato lentivirus and selected for tdTomato expres-
sion using a MoFlo cell sorter. The relative number of
integrated virus particles was normalized to the corre-
sponding level of 18S ribosomal DNA as a loading
control for gene copy number (Fwd ACGGCTACCA
CATCCAAGGA, Rev CCAATTACAGGGCCTCGAAA
[Genbank: NR_046261]).
Immunohistochemistry
Slides were prepared as described [28], with modifi-
cations. Sections were incubated with anti-dsRED (1:50;
Clontech), anti-human progesterone receptor (1:50; Dako-
Cytomation, Carpinteria, CA), anti-human estrogen recep-
tor (clone 6 F11, ThermoFisher Scientific, Waltham, MA),
anti-vimentin (1:100; Millipore), anti-bovine cytokeratin 8/
18 (1:2000; Fitzgerald Industries, Acton, MA), or anti-Ki67
(clone Ab-4; 1:1000; ThermoFisher Scientific) in 5 % horse
serum in PBS at 4 °C overnight and detected with
NovaRED (Vector Laboratories) or DAB (Invitrogen).
Statistics
Differences were assessed by two-way ANOVA, and P-
values calculated using Students t-tests. Data is presented
as means ± SEM, with significance at P < 0.05. For animal
studies, individual mammary glands were treated as the
experimental unit. Animal group sizes were selected to
provide >80 % power to detect differences, taking into
consideration our experience with assessing porcine mam-
mary gland morphology [29] and the typical engraftment
characteristics and rates of primary bovine and human
MEC in immunodeficient mice [30, 31].
Results
Primary culture of porcine mammary cells
Dissociation of mammary tissue from nulliparous pigs
(study one) yielded epithelial organoids that adhered to
plastic within 24 h (Fig. 1). At 2d post-dissociation,
mixed populations of cells included a cytokeratin-
positive epithelial population (luminal), cells positive for
both cytokeratin and vimentin (basal/myoepithelial) and
Fig. 1 Representative images of pig mammary organoids collected
after enzymatic dissociation of mammary gland tissue from a non-
pregnant female. a A cluster of epithelial cells (closed arrowhead) and
piece of duct (open arrowhead) with surrounding outgrowth 24 h after
dissociation and plating. b An organoid with typical outgrowth 48 h
after dissociation. Scale bar = 100 μm
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two morphologically distinct vimentin-positive popula-
tions, one most likely being fibroblasts (Fig. 2).
Lentivirus for manipulating pMEC in vitro and in vivo
We compared the CMV, EF1α and PGK promoters in
lentivirus-transduced pMEC (study one), and determined
EF1α to be the most effective in vitro (Additional file 2:
Figure S2B). We next determined which promoter was
most effective for pMEC in vivo, and the best route
(intraductal or intramammary) for introducing lenti-
virus into the mammary gland (study two). Analysis of
genomic DNA revealed that polybrene increased the in-
corporation of lentivirus instilled intraductally by 24-
fold (Fig. 3a; P < 0.05). We detected tdTomato in 5/9
CMV-, 5/9 EF1α- and in 4/9 PGK-tdTomato glands
injected intraductally with lentivirus (Fig. 3b). In mam-
mary glands receiving intramammary injections of
lentivirus with polybrene we detected tdTomato in 2/8
CMV-, in 4/8 EF1α- and in 5/9 PGK-tdTomato glands
(Fig. 3c). Glands transduced by intraductal instillation
were analyzed for ductal outgrowths expressing tdTomato
(Additional file 3: Figure S3). Clustered tdTomato-positive
structures were present in the mammary gland injected
with either EF1α-tdTomato or CMV-tdTomato lentivirus,
consistent with localized transduction.
We examined whether pMEC transduced ex vivo
would develop into epithelial structures upon transplant-
ation into donor pigs (study three). Expansion of cells
for 8d post-transduction before reinstallation yielded
fluorescent TDLU outgrowths from EF1α-tdTomato
(n = 1 of 8 mammary glands) and CMV-tdTomato (n = 2
of 8) transduced cells (Fig. 4a), but not from PGK-
tdTomato transductants or in control glands (not shown),
despite detection of tdTomato in 2/6 glands transplanted
with PGK-tdTomato pMEC (Fig. 4b). Expansion of cells
for 24 h post-transduction prior to reinstallation led to de-
tection of genomic tdTomato in >50 % of glands injected
with CMV-tdTomato pMEC, EF1α-tdTomato or PGK-
tdTomato transduced cells (Fig. 4c).
Oncogene-induced pMEC transformation in vitro
We compared the efficacy of the three promoters for ex-
pressing the Tag oncoproteins ST, MT and LT produced
by splicing of the murine polyomavirus Tag. Based on
the number of colonies in soft agar, the PGK promoter
was most effective for directing Tag-induced transform-
ation of pMEC in vitro (Additional file 4: Figure S4).
When pMEC transduced with PGK-Tag, CMV-Tag or
EF1α-Tag were injected as isografts, we only detected
dense structures in whole mounts from all PGK-Tag
engrafted glands that were evaluated (Fig. 5a; 2 pigs, 4
mammary glands total). These structures histologically
resembled TDLU (Figs. 5b and c), and were positive for the
expression of estrogen receptor (Additional file 5: Figure
S5A), progesterone receptor (Additional file 5: Figure S5B),
and epithelial cytokeratins (Additional file 5: Figure S5D)
and negative for vimentin (Additional file 5: Figure S5C).
Areas within and surrounding the TDLU were confirmed
to be PGK-Tag positive (Fig. 5d). Subsequent experiments
involving Tag utilized the PGK promoter.
Fig. 2 Representative fluorescence images from pig mammary organoids 48 h after dissociation (P0) and after passages 1 and 2 (P1 and P2). Four
distinct populations of cells were visible at P0. Cytokeratin-positive luminal epithelial cells, vimentin-positive fibroblasts (dashed circle, arrowheads
in P2), cells positive for both vimentin and cytokeratin (dashed rectangle) and small, vimentin- positive cells (solid circle) found infrequently only
at P0
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We next profiled Tag-induced molecular changes in
pMEC. Those pMEC (n = 4 pigs) transduced with PGK-
Tag exhibited increased proliferation and anchorage-
independent growth (Figs. 6a-b). Analysis of the expression
of oncogenes (LEF-1, cyclin A2, cyclin D1, myc) and tumor
suppressor genes (p16, p21, Rb and p53) revealed that Tag-
transduced pMEC had elevated P16 (P = 0.01) and cyclin
A2 mRNA expression (P = 0.03; Fig. 6c). The LT protein
was detected in PGK-Tag transduced pMEC (Fig. 7a), with
upregulated TP53 (P = 0.007) and decreased phosphory-
lated Rb (P = 0.01; Figs. 7c-d) and a tendency for increased
phosphorylated MAPK1/3 (P = 0.13; Fig. 7b). We also re-
fined our transduction protocol using a vector that co-
expressed tdTomato with Tag (PGK-Tag-CMV-tdTomato).
We found that 55 ± 7 % pMEC transduced by PGK-
Tag-CMV-tdTomato were red 7d after transduction
whereas 95 ± 0.5 % were positive for tdTomato 4 weeks
post-transduction (not shown).
FACS sorting of primary pMEC
We separated pMEC using lineage-specific markers pre-
viously used for human and mouse MEC [32]. Stromal
cells were removed by sorting for CD140a. The
remaining pMEC were sorted as CD49f + and CD49f-
that comprised 79 % and 21 %, respectively (P < 0.001).
The CD140a-CD49f- cells were enriched for cytokeratin-
positive and vimentin-negative cells (luminal-like) whereas
CD140a-CD49f + subpopulations were enriched for cyto-
keratin- and vimentin-positive cells (basal-like) (Additional
file 6: Figure S6). Few cytokeratin-negative and vimentin-
Fig. 3 Injection of lentivirus into the pig mammary gland. a Glands were injected intraductally (n = 9 pigs) with CMV-tdTomato, EF1α-
tdTomato or PGK-tdTomato lentivirus with or without polybrene and harvested 5, 10 or 15d later. Lentiviral integration was determined by
qPCR for tdTomato, corrected for 18S ribosomal RNA levels and expressed as a ratio of tdTomato integration with or without polybrene. Data
are means ± SEM (n = 6-7). b Glands were injected intraductally (n = 9 pigs) with CMV-tdTomato, EF1α-tdTomato or PGK-tdTomato lentivirus
and polybrene and harvested 5, 10 or 15d later. c Injections were into the mammary parenchyma (n = 9 pigs) with CMV-tdTomato, EF1α-
tdTomato or PGK-tdTomato lentivirus and polybrene and harvested 5, 10 or 15d later. Negative controls (Neg) are genomic DNA from the
mammary glands of two untreated pigs. Positive controls (Pos) are two pMEC lines transduced with CMV-tdTomato
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positive cells were present in CD140a- CD49f + populations
(0.07 % +/- 0.03, second passage).
Dissociated pMEC depleted for CD140a (CD140a-, n = 5;
Table 1) and enriched for CD49f (CD140a-CD49f + n = 2;
Table 1) were transduced with PGK-Tag-CMV-tdTomato,
and some further enriched for tdTomato (CD140a-
tdTomato+; n = 3; Table 1). Cells sorted for CD140a-
tdTomato + exhibited red fluorescence in vitro (Additional
file 7: Figure S7A). Transduction by PGK-Tag-CMV-
tdTomato yielded transformed pMEC that gave rise to
colonies able to grow in soft agar (Figure S7B) expressing
ST, MTand LT (not shown).
Populations of pMEC transduced by PGK-Tag-
CMV-tdTomato varied morphologically in vitro. While
CD140a-CD49f + pMEC retained a cobblestone morphology
(Additional file 8: Figure S8A), CD140a-tdTomato+ pMEC
were elongated (Additional file 8: Figure S8B), developed foci
(Additional file 8: Figure S8C) or maintained a cobblestone
morphology without foci (Additional file 8: Figure S8D).
Transformed xenografted pMEC generate orthotopic and
ectopic tumors
To determine the tumorigenicity of transformed pMEC,
all cell lines were injected into NSG mice either
subcutaenously with hydrogel or Matrigel, or into the
mammary fat pads. Cells injected in the fat pad, either in
Matrigel or hydrogel, failed to form tumors after
36 weeks (n = 5; Table 1). There were striking differences
among tumors that formed subcutaneously following co-
injection with Matrigel or hydrogel. While all trans-
formed pMEC in Matrigel developed tumors (>1 mm)
after 4 weeks, only one line in hydrogel developed tu-
mors after 16 weeks (Table 1).
Tumors from CD140a-CD49f + PGK-Tag-CMV-tdTo-
mato pMEC injected with Matrigel or hydrogel were
54–74 % positive for red fluorescence (Additional file 9:
Figure S9A-B). Tumors comprised mixed neoplastic
glandular epithelium and nests of squamous epithelium
having intracellular bridges and dyskeratosis with occa-
sional microcalcifications and dense fibrosis (Fig. 8a-d).
Immunohistochemistry for cytokeratin 8/18, Ki-67 and
nuclear hormone receptors confirmed these tumors were
epithelial and proliferative (Figs. 8e-f ), albeit negative for
estrogen receptor (Fig. 8g) and progesterone receptor
(not shown). Tumors arising from CD140a- PGK-Tag-
CMV-tdTomato pMEC co-injected subcutaneously with
Matrigel were <50 % red (Additional file 9: Figure S9E)
and contained occasional nests of squamous epithelium
Fig. 4 Installation of lentivirus-transduced pig mammary epithelial cells (pMEC). a Representative images of red fluorescent terminal ductal
lobular units identified in whole mounts of mammary glands injected with pMEC 8d after the cells were transduced with CMV-tdTomato,
EF1α-tdTomato or PGK-tdTomato lentivirus. Tissues were harvested 3 or 5 weeks later. b Detection of tdTomato by PCR of genomic DNA from
mammary glands analyzed in (a). Negative controls (Neg) are genomic DNA from the mammary glands of two untreated pigs. c Detection of
tdTomato by PCR of genomic DNA from mammary glands injected with pMEC 24 h after the cells were transduced with CMV-tdTomato,
EF1α-tdTomato or PGK-tdTomato lentivirus. Tissues were harvested 4 weeks later
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mixed with glandular epithelium (Fig. 8h-i). Whole
mount analysis revealed red fluorescent growths in the
mammary fat pads of mice carrying CD140a- pMEC in
Matrigel (6/8 injections; Additional file 9: Figure S9D)
that were subsequently found to comprise non-
neoplastic ducts or cysts (Fig. 8f ), similar to results for
normal human and bovine MEC transplanted into the
mouse mammary fat pad [31, 30].
We recorded variation among growths arising from
CD140- pMEC instilled with hydrogel. One line of trans-
formed pMEC only yielded microscopic fluorescent
growths (Additional file 9: Figure S9E), which contained fi-
brosis and neoplastic squamous epithelial cells (Fig. 8j-k). A
second line developed palpable mammary and subcutane-
ous tumors that were comprised chiefly of fibrous connect-
ive tissue. Accordingly, these tumors were strongly
vimentin-positive with only scant dsRED immunoreactivity
(not shown). A third line of CD140a-tdTomato + pMEC
injected in hydrogel infrequently developed tumors in the
mammary fat pad (1/8 injections; not shown) that com-
prised non-neoplastic ducts (not shown) similar to those
found for pMEC co-instilled with Matrigel (Fig. 8h).
Discussion
Here we report the first successful lentivirus-mediated
transgenesis and transformation of primary pMEC
in vitro and in vivo. Given significant structural and
functional similarities between the mammary glands of
pigs and humans [9], our approach is a first step toward
a promising animal model in which to investigate the
tissue-level cellular and environmental interactions be-
hind human breast development and oncogenesis.
A variety of genetically-engineered mouse models has
enabled the identification of various genes involved in
mammary cancer initiation and progression, yet the result-
ing tumors often differ in their pathology compared to hu-
man breast cancers [33]. This discordance may reflect the
greater frequency at which mouse tumors develop from al-
veolar structures [33] compared to those of the human
breast that often arise from less-differentiated TDLU-1 and
-2 [17]. As such, investigations into the initiation and pro-
gression of tumors within TDLU have been hampered by
the absence of similar structures in the mouse mammary
gland alongside the challenges associated with obtaining
human tissues. Development of a pig breast cancer pre-
clinical model stands to complement recent advances to
optimize the limitations of mouse models such as the
addition of human stromal elements to the mouse mam-
mary fat pad [34] and reconstitution of the mouse mam-
mary epithelium with human preneoplastic cells [35].
Our techniques enable transformation of MEC derived
from the TDLU of pre- and peripubescent pigs that are
Fig. 5 PGK-Tag transformed pMEC promote the precocious development of dense epithelial structures that resemble terminal ductal lobular units (TDLU).
a Whole mounts of mammary glands injected with either pMEC transduced with PGK-Tag lentivirus or non-transduced pMEC (control mammary gland). b
Densely packed structures identified by whole mount analysis of PGK-Tag engrafted mammary glands were sectioned and stained (H&E). A
parenchyma-rich area from a contralateral control mammary gland is included for comparison. Scale bar =100 μm. c Magnification of H&E
from (a) scale bar = 100 μm. d PCR detection of PGK-Tag in genomic DNA from paraffin sections of the mammary gland shown in (b). Positive
control is genomic DNA from pMEC transduced with PGK-Tag. Negative is ddH2O template
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synonymous with TDLU-1 and -2 in the human breast
[9]. Moreover, vacuum-assisted mammary biopsies [19],
which are impractical in rodents [36], will allow serial
sampling of a pig model of breast cancer to study the re-
sponse to cancer treatment over time, or the influence
of environmental and lifestyle factors on breast cancer
risk. While a porcine pre-clinical model has limitations
including increased cost and housing requirements [36],
these drawbacks are countered by the potential ability to
authentically model normal human breast development
and breast cancers within a context that is biologically
and physiologically more similar to the human.
The human breast and pig mammary gland have a
similarly complex stromal microenvironment, which
contrasts to that of the rodent mammary gland [18].
Our results highlight the influence of stromal factors on
the occurrence and rate of pMEC tumor formation
in vivo. Similar to transformed human breast epithelial
cells [37], transformed pMEC failed to form tumors in
the microenvironment of the mouse mammary fat pad
despite developing tumors ectopically. Our data corrob-
orates previous evidence showing that elements of the
mouse mammary fat pad are inadequate to support
proliferation of non-native epithelium [18]. These data,
alongside work by others [34, 31, 30], adds to evidence
highlighting differences between species in the stroma-
directed behavior of the mammary epithelium. Indeed,
attempts to reconstruct human [31] or bovine [30]
mammary tissues in the mouse mammary fat pad by xe-
nografting tissue fragments or dissociated MEC failed to
generate species-specific TDLU.
Given that the pig mammary gland is rich in connect-
ive tissues, co-inoculating irradiated pig stromal fibro-
blasts with transformed pMEC may have increased their
viability when xenografted into the mouse mammary fat
pad, as for human and bovine MEC [34, 38]. Along these
same lines, Matrigel promoted transformed pMEC to
form tumors, consistent with the stromal requirements
of xenografts of human breast cancer cells [39]. The
matrix proteins found in Matrigel can support the
growth of cells in a foreign environment, recapitulating
the connective-tissue rich stroma of the human breast
and pig mammary gland [18, 40]. However, unlike in
humans, mammary carcinomas are extremely rare in
pigs [41]. This low incidence may reflect innate repres-
sive effects of the stroma, which can restrain the
Fig. 6 Pig mammary epithelial cells (pMEC) transduced with PGK-Tag lentivirus exhibit a transformed phenotype. a Growth of pMEC transduced
with PGK-Tag (n = 4) and control pMEC transduced with CMV-tdTomato (n = 3). b Representative image of PGK-Tag transduced pMEC in soft agar.
PGK-Tag pMEC formed 753.3 ± 30 colonies/well while CMV-tdTomato pMEC yielded no colonies. c pMEC transduced with PGK-Tag (n = 4) or PGK-
Tag-CMV-tdTomato (n = 1) had similar expression of cyclin D1, myc, p53 and Rb and increased expression of cyclin A2 and p16 (*P < 0.05)
compared to control pMEC
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tumorigenicity of undifferentiated mouse embryonic car-
cinoma cells [42] and prevents marginally abnormal hu-
man mammary organoids developing hyperplasias in
humanized mouse mammary fat pads [34]. The structure
and morphology of tumor stroma associated with xeno-
grafts differs from normal stroma [43], suggesting that
changes within tumor stroma may be more permissive.
Accordingly, transformed porcine dermal fibroblasts
readily formed undifferentiated sarcomas in the mam-
mary glands of immunosuppressed pigs [44], while we
found that isogenic transplanted pMEC transformed by
Tag failed to form palpable tumors in immunocompe-
tent pigs (data not shown). While immunosuppression
may have increased the take of transformed pMEC [44],
it is also possible that transformation of stromal cells is
also required to induce mammary carcinomas in pigs.
As such, future work to overcome these repressive
mechanisms and develop the pig as an authentic breast
cancer model may open up hitherto unexplored mecha-
nisms to defeat breast cancer.
We transformed pMEC by lentivirus-mediated ex-
pression of murine Tag proteins. While Tag or similar
viral oncoproteins have not been directly implicated in
human breast carcinogenesis, Tag activates various on-
cogenes and bypasses p53 and Rb [45, 46] as in many
human breast cancers [47, 48]. Mammary tumors that
develop from germline transgenic MT expression in
the mouse mimic invasive human breast carcinomas
Fig. 7 PGK-Tag transduced pMEC have altered oncogene expression. a Proteins from pMEC (n = 3), pMEC-PGKTag (n = 4) and an NSG mouse
tumor from injection of pMEC-PGK-Tag-CMV-tdTomato cells (n = 1) were analyzed by western blot for ST, MT and LT. b Western blot of the same
proteins using b) anti-MAPK1/3, anti-phospho MAPK1/3, anti-cyclin D1 and anti-β-actin antibodies, and c) anti-Rb, anti-phospho Rb, anti-p53 and
anti-β-actin. d Protein levels from blots in b) and c) were quantified for pMEC (n = 3) and pMEC-PGKTag cells (n = 5)
Rowson-Hodel et al. BMC Cancer  (2015) 15:562 Page 12 of 16
with progressive loss of ER coincident with increased
invasiveness [49]. Herein, Tag-transformed pMEC de-
veloped estrogen receptor- negative, proliferative tu-
mors when xenografted to mice. Interestingly, pMEC
co-injected with Matrigel into estrogen-treated mice
displayed a shorter latency to tumor formation, raising
the possibility that transformed pMEC may have ini-
tially been hormone-sensitive. Given that mice carrying
pMEC co-injected with hydrogel were not treated with es-
trogen, we cannot ascribe any differences in tumor forma-
tion rates to hormone supplementation. Nevertheless, our
observations are consistent with similar findings in a mouse
explant model of transgenic MT [50].
Previous reports indicate that primary human MEC re-
quire disruption of multiple pathways for complete
transformation [37, 51, 35] whereas rodent cells can be
transformed by two oncogenes [52]. Along these lines,
primary pig fibroblasts [44] and human breast epithelial
cells [51] were transformed by sequential transduction
with dominant negative p53, activated CYCLIN-
dependent kinase complex (Cyclin D1/CDK4), c-Myc,
H-Ras and telomerase. Our approach provides for the
Fig. 8 Xenografted CD140-CD49+ pMEC transduced with PGK-Tag-CMV-tdTomato injected subcutaneously with Matrigel or hydrogel produce
epithelial neoplasms. a Section (H&E) from a CD140-CD49+ PGK-Tag-CMV-tdTomato tumor in Matrigel showing neoplastic glandular epithelium.
Scale bar = 600 μm. b Magnified encircled area in (a). Scale bar = 100 μm. c Section (H&E) from a CD140-CD49+ PGK-Tag-CMV-tdTomato tumor in
hydrogel showing neoplastic glandular epithelium. Scale bar = 600 μm. d Magnified encircled area in (c). Scale bar = 100 μm. Immunolocalization
of (e) cytokeratins 8/18, (f) Ki67 and (g) estrogen receptor in CD140-CD49+ PGK-Tag-CMV-tdTomato tumorous pMEC injected with Matrigel. Scale
bar = 100 μm. h CD140- pMEC transduced with PGK-Tag-CMV-tdTomato develop ductal-like structures as subcutaneous xenografts. Section (H&E)
depicting scattered glandular epithelium with hollow or cell-filled lumens. Scale bar = 600 μm. i Magnified encircled area in (h). Scale bar = 100 μm.
j CD140-tdTomato + pMEC transduced with PGK-Tag-CMV-tdTomato produce epithelial-type neoplasms in mammary fat pads. Section (H&E) depicting
fibrosis with neoplastic squamous epithelium. Scale bar = 600 μm. k Magnified encircled area in (j). Scale bar = 100 μm
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efficient induction of tumorigenesis in primary pMEC
by lentivirus-mediated expression of Tag, which upre-
gulates multiple oncogenic pathways. This approach led
to the formation of heterogeneous tumors, perhaps as a
consequence of lentiviral transduction. Along these lines,
transgenic expression of MT in the mouse mammary
gland induced homogenous luminal, solid adenocarcin-
omas [53] whereas low levels of lentivirus-directed MT
transformed both luminal and basal MEC, leading to con-
comitant heterogeneity among the tumors [54]. One fur-
ther explanation may be variable Tag expression within
pMEC subpopulations. Consistent with this postulate, the
degree of Ras expression in transformed primary human
MEC correlated with tumorigenicity in vivo [37]. Interest-
ingly human MEC transformed with Ras-SV40 ST/LT-
hTERT formed poorly differentiated squamous tumors
when xenografted to the mammary fat pad of immuno-
compromised mice [37], similar to our findings with xeno-
grafted pMEC transformed by Tag. Although squamous
differentiation is rare among human breast carcinomas, it
is a phenotype that has been linked to Wnt activation [55],
which has been associated with basal-like and receptor
negative breast cancers [56]. Transformation of pMEC
by alternative oncogenes may yield tumors with dis-
tinct histopathologies and hormone receptor profiles.
In addition, our data indicate that selecting pMEC for
CD49f + enhanced the subsequent formation of lu-
minal breast carcinomas, yielding tumors with luminal
differentiated epithelium, whereas unenriched pMEC
developed as normal ductal structures or fibrous tumors
with and without squamous epithelium. It is possible that
selection for CD49+/EpCAM+ cells in combination with
culture conditions to increase ErbB3 expression over
EGFR expression may increase the likelihood of generat-
ing luminal adenocarcinomas [35].
Conclusions
We have developed an approach for transforming por-
cine mammary epithelium. Our data point to similarities
between the responses of pMEC and human MEC when
xenografted to the mouse mammary fat pad, highlighting
candidate differences in stromal requirements for onco-
genesis across species. These studies lay the basis for in-
vestigating complex interactions underlying human
breast cancer initiation and progression.
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Additional file 1: Figure S1. Plasmid maps of lentiviral vectors. (A) Map
of the construct pLVX-IRES-tdTomato (CMV-tdTomato) wherein the CMV
promoter directs tdTomato expression. The CMV promoter was replaced
by the EF1α or PGK promoter to create EF1α-tdTomato or PGK-tdTomato.
(B) To generate the pLVX-PGK-Tag-CMV-tdTomato vector, the pLVX-PGK-
Tag vector was first created by replacing the IRES and tdTomato from the
vector PGK-tdTomato with murine polyomavirus T antigen that encodes
small T (ST), middle T (MT) and large T (LT) antigens. The CMV promoter
and tdTomato coding sequence were sequentially added to the vector,
creating a pLVX-PGK-Tag-CMV interim vector and the final expression
vector pLVX-PGK-Tag-CMV-tdTomato. (PDF 155 kb)
Additional file 2: Figure S2. Transduction of pMEC by CMV-, EF1α- and
PGK-TdTomato lentivirus. (A) Representative bright field and corresponding
fluorescent images of primary pMEC at passage 0, 7d after transduction by
CMV-tdTomato, EF1α-tdTomato or PGK-tdTomato lentiviral constructs. (B)
Quantification of cells expressing tdTomato, as a measure CMV, EF1α and
PGK promoter activity in pMEC. (PDF 1353 kb)
Additional file 3: Figure S3. Lentiviral integration following intraductal
injection of lentivirus encoding CMV-tdTomato, EF1α-tdTomato or PGK-
tdTomato (n = 9 pigs/lentiviral construct). Mammary tissues were
harvested 5d post-injection, processed into paraffin and sections
analyzed by immunohistochemical detection of dsRED (monomer of
tdTomato) with using NovaRed for detection and a hematoxylin
counterstain. The control section was not exposed to the dsRED
antibody. The negative section is from a gland that was not injected
with tdTomato expressing lentivirus. Scale bar = 100 μm. (PDF 624 kb)
Additional file 4: Figure S4. The promoter of large, middle and small T
antigen (Tag) expression affected the rate of anchorage-independent colony
formation. Representative images from three replicate experiments to measure
soft-agar colony formation by pMEC (n= 2 wells/construct) transduced with
CMV-Tag, EF1α-Tag, PGK-Tag or CMV-tdTomato lentivirus (MOI of 100).
NIH-3 T3 cells were transduced with the same constructs as a positive control.
Cells transduced by CMV-tdTomato served as negative control. (PDF 508 kb)
Additional file 5: Figure S5. Immunohistological features of the dense
epithelial structures that appeared after isotopic engraftment of PGK-Tag
transformed pMEC. Representative images detailing the expression of
(A) estrogen receptor (B) progesterone receptor (C) vimentin and (D)
cytokeratin. Scale bar = 100 μm. (PDF 9416 kb)
Additional file 6: Figure S6. Vimentin and cytokeratin expression in
CD49f-/+ populations. Representative images depicting cytokeratin (red)
and vimentin (green) expression in FACS sorted pMEC. Cells affixed to
glass slides were stained by immunofluorescence for both pan-
cytokeratin and vimentin. (A) CD140-CD49- pMEC. (B) CD140a-CD49f +
pMEC at passages 2 (P2), 3 (P3) and 5 (P5). Vimentin-only positive cells
are circled. (PDF 846 kb)
Additional file 7: Figure S7. Porcine mammary epithelial cells (pMEC)
were transduced with PGK-Tag-CMV-TdTomato (PGK-Tag-CMV-tdT)
lentivirus, cultured for 7d then sorted using a MoFlo for (A) tdTomato
fluorescence. (B) The sorted tdTomato + cells were plated into a soft
agar assay alongside CMV-TdTomato transduced pMEC. (PDF 1741 kb)
Additional file 8: Figure S8. Representative images depicting
differential in vitro morphology of populations of pMEC transduced by
PGK-Tag-CMV-tdTomato lentivirus. Red fluorescence (RFP) is included to
illustrate the percentage of transduced cells. (A) Transduced CD140a-
CD49f + pMEC retained a cobblestone morphology characteristic of
MEC. (B) Transduced CD140a-tdTomato + pMEC from pig 27-3 grew as
elongated cells. (C) Transduced CD140- pMEC from pig 28-3 devel-
oped foci in vitro rather than as a monolayer. (D) Transduced CD140-
tdTomato + pMEC from pig 28-6 grew as sheets of cobblestone
epithelium with few foci. (PDF 1137 kb)
Additional file 9: Figure S9. Bright field and red fluorescence (RFP) in
a xenograft subcutaneous tumor excised from a mouse carrying
CD140-CD49+ PGK-Tag-CMV-tdTomato pMEC (ss020513_1) in hydrogel
(A) or Matrigel (B). Scale bar = 1 mm. (C) Bright field and RFP of a
CD140- PGK-Tag-CMV-tdTomato tumor (ss082112) in Matrigel. Scale
bar = 1 mm. Bright field and RFP of microscopic growths in mammary
fat pads injected with CD140- pMEC transduced with PGK-Tag-CMV-
tdTomato co-injected with (D) Matrigel (ss082112) or (E) hydrogel. Scale
bar = 500 μm. (PDF 1166 kb)
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